Literature DB >> 15947403

Prognosis without treatment as a modifier in health economic assessments.

Ross Camidge1, Andrew Walker, James J Oliver, Fiona Nussey, Simon Maxwell, Duncan Jodrell, David J Webb.   

Abstract

Mesh：

Year:  2005        PMID： 15947403      PMCID： PMC558296          DOI： 10.1136/bmj.330.7504.1382

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  12 in total

1.  Choosing the method to match the perspective: economic assessment and its implications for health-services efficiency.

Authors:  Adam Oliver; Andrew Healey; Cam Donaldson
Journal:  Lancet       Date:  2002-05-18       Impact factor: 79.321

2.  Priority setting in health care: learning from international experience.

Authors:  C Ham
Journal:  Health Policy       Date:  1997-10       Impact factor: 2.980

3.  Challenges for the National Institute for Clinical Excellence.

Authors:  Alan Maynard; Karen Bloor; Nick Freemantle
Journal:  BMJ       Date:  2004-07-24

4.  National Institute for Clinical Excellence and its value judgments.

Authors:  Michael D Rawlins; Anthony J Culyer
Journal:  BMJ       Date:  2004-07-24

Review 5.  The use of QALYs in health care decision making.

Authors:  G Loomes; L McKenzie
Journal:  Soc Sci Med       Date:  1989       Impact factor: 4.634

6.  A test of the QALY model when health varies over time.

Authors:  Anne Spencer
Journal:  Soc Sci Med       Date:  2003-11       Impact factor: 4.634

7.  The rationing debate. Rationing health care by age.

Authors:  A Williams; J G Evans
Journal:  BMJ       Date:  1997-03-15

Review 8.  Efficacy and cost-effectiveness of cancer treatment: rational allocation of resources based on decision analysis.

Authors:  T J Smith; B E Hillner; C E Desch
Journal:  J Natl Cancer Inst       Date:  1993-09-15       Impact factor: 13.506

9.  Age and clinical decision making in oncology patients.

Authors:  S B Yellen; D F Cella; W T Leslie
Journal:  J Natl Cancer Inst       Date:  1994-12-07       Impact factor: 13.506

10.  Cost-effectiveness analysis in a setting of budget constraints--is it equitable?

Authors:  P A Ubel; M L DeKay; J Baron; D A Asch
Journal:  N Engl J Med       Date:  1996-05-02       Impact factor: 91.245
View more
  4 in total

1.  A middle way for rationing healthcare resources.

Authors:  Rudolf Klein
Journal:  BMJ       Date:  2005-06-11

2.  The impact of prognosis without treatment on doctors' and patients' resource allocation decisions and its relevance to new drug recommendation processes.

Authors:  D Ross Camidge; James J Oliver; Carolyn Skinner; Ben Attwood; Fiona Nussey; Duncan Jodrell; David J Webb
Journal:  Br J Clin Pharmacol       Date:  2008-02       Impact factor: 4.335

3.  The role of economic evaluation in the decision-making process of family physicians: design and methods of a qualitative embedded multiple-case study.

Authors:  Chantale Lessard; André-Pierre Contandriopoulos; Marie-Dominique Beaulieu
Journal:  BMC Fam Pract       Date:  2009-02-11       Impact factor: 2.497

4.  Cost-effectiveness analysis of cetuximab/irinotecan vs active/best supportive care for the treatment of metastatic colorectal cancer patients who have failed previous chemotherapy treatment.

Authors:  N Starling; D Tilden; J White; D Cunningham
Journal:  Br J Cancer       Date:  2007-01-29       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.